We further tested several inhibitors targeting microenvironment-associated kinases (BTK, PI3K, RAF, P38, MEK, ERK), revealing that CLL proliferation is highly sensitive to RAF inhibitors. The gene discussed is MAP2K7; the disease is B-cell chronic lymphocytic leukemia.